Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/2182892

J. Natl. Cancer Inst. 1990 May 2 82 9 763-71

Download in:

View as

Triples

General Info

PMID
2182892